Protalix BioTherapeutics Inc (AMEX:PLX) does about 908.84K shares in volume on a normal day but saw 12690476 shares change hands in the recent trading day. The company now has a market cap of 122.59M USD. Its current market price is $1.54, marking an increase of 6.21% compared to the previous close of $1.45. The 52 week high reached by this stock is $3.10 whilst the lowest price level in 52 weeks is $0.82.
The consensus objective for the share price is $15.00, suggesting that the stock has a potential upside of 89.73% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 08, 2020 when H.C. Wainwright reiterated the stock to “Buy” and issued a price target of between $3 and $11. Rodman & Renshaw initiated its price target at $3.50.
The current price level is 2.56%, -21.68%, and -17.93% away from its SMA20, SMA50, and SMA200 respectively, with the PLX price moving above the 50-day SMA on current market day. Protalix BioTherapeutics Inc (PLX) stock is up 10.00% over the week and -3.14% over the past month. Its price is 19.38% year-to-date and -18.09% over the past year.
To reach the target analysts have set, the stock logically needs to grow 89.73 percent from here.
The company has a return on investment of 7.97% and return on equity of 10.42%. The price to earnings ratio (P/E ratio) amounts to 36.67 while the forward price to earnings ratio is 3.42. The beta has a value of -0.23. Price to book ratio is 2.66 and price to sales ratio is 2.05.
